Deal · Agreement signed
Passage BIO, Inc. and Remix continuing as a wholly owned subsidiary of the Company and the surviving
First filed 3 Sept 2026, 1 filing.
The deal
- Buyer
- Passage BIO, Inc.
- Target
- Remix continuing as a wholly owned subsidiary of the Company and the surviving
- Status
- Agreement signed
- Region
- US
Entry into a Material Definitive Agreement. Amended and Restated Merger Agreement As previously disclosed, on June 24, 2026, Passage Bio, Inc.
Source: The filing (SEC Form 8-K)
With a free account
A free account opens 10 full pages a month and lets you follow this page: alerts on the next filing, buyer lists, exports.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.